Trial intelligence / Profile preview

Nicotine Lozenge for Cue-Induced Craving

NCT02347605Completed

Sponsor
University of Minnesota
Start
Sep 2013
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nicotine in Tobacco Use Disorder (TUD) (3 arms), sponsored by University of Minnesota. Primary endpoints: Craving Symptom Severity at 15 minutes and Withdrawal Symptom Severity at 15 minutes. Started Sep 2013; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT02347605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02347605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call